Skip to main content
Top
Published in: Clinical & Experimental Metastasis 6/2011

01-08-2011 | Research Paper

Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion

Authors: Shizhuo Wang, Shulan Zhang

Published in: Clinical & Experimental Metastasis | Issue 6/2011

Login to get access

Abstract

Dickkopf-1 (DKK1) was known as a negative regulator of the Wnt signaling pathway, which played a crucial role in carcinogenesis. However, its function in human cancers remained elusive. In this study, we aimed to investigate the role of DKK1 in ovarian serous papillary adenocarcinoma (OSC) tumor progression and invasion. Quantitative real-time RT–PCR and Western blot analysis showed that the expression of DKK1 mRNA and protein in 32 OSC tissues were elevated as compared with those in 10 normal ovarian tissues (P = 0.005, P = 0.003, respectively). Immunohistochemical analysis in 178 clinical OSC samples showed that the expression of DKK1 was positively associated with FIGO stage (P = 0.016). Furthermore, the expression of DKK1 protein was positively associated with P-JNK1 protein expression in 178 OSC tissues. DKK1, P-JNK1 and the co-expression of DKK1 and P-JNK1 were all unfavorable prognosis factors for OSC patients (P < 0.0001). DKK1, alone or combined with P-JNK1, was an independent predictor for the 5 year survival (P = 0.015, P < 0.0001, respectively). DKK1 could promote OSC cells invasion and the growth of OSC nude mice xenograft. DKK1 in OSC cells could activate P-JNK1 expression and significantly promote formations of actin filaments and filopodia. Thus, DKK1, alone or combined with P-JNK1, was a novel prognostic predictor for OSC patients and contributed to the invasion of OSC.
Literature
1.
go back to reference Peifer M, Polakis P (2000) Wnt signaling in oncogenesis and embryogenesis—a look outside the nucleus. Science 287:1606–1609PubMedCrossRef Peifer M, Polakis P (2000) Wnt signaling in oncogenesis and embryogenesis—a look outside the nucleus. Science 287:1606–1609PubMedCrossRef
2.
go back to reference Polakis P (2007) The many ways of Wnt in cancer. Curr Opin Genet Dev 7:45–51CrossRef Polakis P (2007) The many ways of Wnt in cancer. Curr Opin Genet Dev 7:45–51CrossRef
3.
go back to reference Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781–810PubMedCrossRef Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781–810PubMedCrossRef
4.
go back to reference Niehrs C (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25:7469–7481PubMedCrossRef Niehrs C (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25:7469–7481PubMedCrossRef
5.
go back to reference Krupnik VE, Sharp JD, Jiang C et al (1999) Functional and structural diversity of the human Dickkopf gene family. Gene 238:301–313PubMedCrossRef Krupnik VE, Sharp JD, Jiang C et al (1999) Functional and structural diversity of the human Dickkopf gene family. Gene 238:301–313PubMedCrossRef
6.
go back to reference Glinka A, Wu W, Delius H et al (1998) Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391:357–362PubMedCrossRef Glinka A, Wu W, Delius H et al (1998) Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391:357–362PubMedCrossRef
7.
go back to reference Wu W, Glinka A, Delius H, Niehrs C (2000) Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/beta-catenin signalling. Curr Biol 10:1611–1614PubMedCrossRef Wu W, Glinka A, Delius H, Niehrs C (2000) Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/beta-catenin signalling. Curr Biol 10:1611–1614PubMedCrossRef
8.
go back to reference Niida A, Hiroko T, Kasai M et al (2004) DKK1, a negative regulator of Wnt signaling, is a target of theβ-catenin/TCF pathway. Oncogene 23:8520–8526PubMedCrossRef Niida A, Hiroko T, Kasai M et al (2004) DKK1, a negative regulator of Wnt signaling, is a target of theβ-catenin/TCF pathway. Oncogene 23:8520–8526PubMedCrossRef
9.
go back to reference Gonzalez-Sancho JM, Aguilera O, Garcia JM et al (2005) The Wnt antagonist DICKKOPF-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer. Oncogene 24:1098–1103PubMedCrossRef Gonzalez-Sancho JM, Aguilera O, Garcia JM et al (2005) The Wnt antagonist DICKKOPF-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer. Oncogene 24:1098–1103PubMedCrossRef
10.
go back to reference Wirths O, Waha A, Weggen S et al (2003) Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms’ tumors. Lab Invest 83:429–434PubMed Wirths O, Waha A, Weggen S et al (2003) Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms’ tumors. Lab Invest 83:429–434PubMed
11.
go back to reference Forget MA, Turcotte S, Beauseigle D et al (2007) The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br J Cancer 96:646–653PubMedCrossRef Forget MA, Turcotte S, Beauseigle D et al (2007) The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br J Cancer 96:646–653PubMedCrossRef
12.
go back to reference Yamabuki T, Takano A, Hayama S et al (2007) Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res 67:2517–2525PubMedCrossRef Yamabuki T, Takano A, Hayama S et al (2007) Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res 67:2517–2525PubMedCrossRef
13.
go back to reference Yu B, Yang X, Xu Y et al (2009) Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. J Hepatol 50:948–957PubMedCrossRef Yu B, Yang X, Xu Y et al (2009) Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. J Hepatol 50:948–957PubMedCrossRef
14.
go back to reference Voorzanger-Rousselot N, Goehrig D, Journe F et al (2007) Increased Dickkopf-1 expression in breast cancer bone metastases. Br J Cancer 97:964–970PubMed Voorzanger-Rousselot N, Goehrig D, Journe F et al (2007) Increased Dickkopf-1 expression in breast cancer bone metastases. Br J Cancer 97:964–970PubMed
15.
go back to reference Hall CL, Kang S, MacDougald OA et al (2006) Role of Wnts in prostate cancer bone metastases. J Cell Biochem 97:661–672PubMedCrossRef Hall CL, Kang S, MacDougald OA et al (2006) Role of Wnts in prostate cancer bone metastases. J Cell Biochem 97:661–672PubMedCrossRef
16.
go back to reference Shizhuo W, Tao J, Shulan Z et al (2009) The expression and significance of Dickkopf-1 in epithelial ovarian carcinoma. Int J Biol Markers 24:165–170PubMed Shizhuo W, Tao J, Shulan Z et al (2009) The expression and significance of Dickkopf-1 in epithelial ovarian carcinoma. Int J Biol Markers 24:165–170PubMed
17.
go back to reference Torres MP, Ponnusamy MP, Lakshmanan I et al (2009) Immunopathogenesis of ovarian cancer. Minerva Med 100:385–400PubMed Torres MP, Ponnusamy MP, Lakshmanan I et al (2009) Immunopathogenesis of ovarian cancer. Minerva Med 100:385–400PubMed
18.
19.
go back to reference Gómez-Raposo C, Mendiola M, Barriuso J et al (2010) Molecular characterization of ovarian cancer by gene-expression profiling. Gynecol Oncol 118:88–92PubMedCrossRef Gómez-Raposo C, Mendiola M, Barriuso J et al (2010) Molecular characterization of ovarian cancer by gene-expression profiling. Gynecol Oncol 118:88–92PubMedCrossRef
20.
go back to reference Jarboe JS, Johnson KR, Choi Y et al (2007) Expression of interleukin-13 receptor α2 in glioblastoma multiforme: implications for targeted therapies. Cancer Res 67:7983–7986PubMedCrossRef Jarboe JS, Johnson KR, Choi Y et al (2007) Expression of interleukin-13 receptor α2 in glioblastoma multiforme: implications for targeted therapies. Cancer Res 67:7983–7986PubMedCrossRef
21.
go back to reference Hao XP, Pretlow TG, Rao JS et al (2001) Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res 61:8085–8088PubMed Hao XP, Pretlow TG, Rao JS et al (2001) Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res 61:8085–8088PubMed
22.
go back to reference Endo Y, Beauchamp E, Woods D et al (2008) Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3- and c-Jun N-terminal kinase-dependent mechanism. Mol Cell Biol 28:2368–2379PubMedCrossRef Endo Y, Beauchamp E, Woods D et al (2008) Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3- and c-Jun N-terminal kinase-dependent mechanism. Mol Cell Biol 28:2368–2379PubMedCrossRef
23.
go back to reference Xia Y, Karin M (2004) The control of cell motility and epithelial morphogenesis by Jun kinases. Trends Cell Biol 14:10–94CrossRef Xia Y, Karin M (2004) The control of cell motility and epithelial morphogenesis by Jun kinases. Trends Cell Biol 14:10–94CrossRef
24.
go back to reference Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3:362–374PubMedCrossRef Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3:362–374PubMedCrossRef
25.
go back to reference Wang W, Goswami S, Lapidus K et al (2004) Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 64:8585–8594PubMedCrossRef Wang W, Goswami S, Lapidus K et al (2004) Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 64:8585–8594PubMedCrossRef
26.
go back to reference Seoud M, Salem Z, Shamseddine A et al (1999) Papillary serous carcinoma of the ovary following prolonged tamoxifen treatment. Eur J Gynaecol Oncol 20:237–239PubMed Seoud M, Salem Z, Shamseddine A et al (1999) Papillary serous carcinoma of the ovary following prolonged tamoxifen treatment. Eur J Gynaecol Oncol 20:237–239PubMed
27.
go back to reference Vivas-Mejia P, Benito JM, Fernandez A et al (2010) c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer. Clin Cancer Res 16:184–194PubMedCrossRef Vivas-Mejia P, Benito JM, Fernandez A et al (2010) c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer. Clin Cancer Res 16:184–194PubMedCrossRef
Metadata
Title
Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion
Authors
Shizhuo Wang
Shulan Zhang
Publication date
01-08-2011
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 6/2011
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-011-9393-9

Other articles of this Issue 6/2011

Clinical & Experimental Metastasis 6/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine